Citação norma APA

Gottlieb, A. B., Strand, V., Kishimoto, M., Mease, P., Thaçi, D., Birt, J., . . . Gladman, D. D. (2018). Ixekizumab improves patient-reported outcomes up to 52 weeks in bDMARD-naïve patients with active psoriatic arthritis (SPIRIT-P1). Rheumatology (Oxford).

Citação norma Chicago

Gottlieb, Alice B., et al. "Ixekizumab Improves Patient-reported Outcomes Up to 52 Weeks in BDMARD-naïve Patients With Active Psoriatic Arthritis (SPIRIT-P1)." Rheumatology (Oxford) 2018.

Citação norma MLA

Gottlieb, Alice B., et al. "Ixekizumab Improves Patient-reported Outcomes Up to 52 Weeks in BDMARD-naïve Patients With Active Psoriatic Arthritis (SPIRIT-P1)." Rheumatology (Oxford) 2018.

Nota: a formatação da citação pode não corresponder 100% ao definido pela respectiva norma.